Literature DB >> 24418540

Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.

Yusuke Matsui1, Keisuke Shindo2, Kayoko Nagata1, Katsuhiro Io1, Kohei Tada1, Fumie Iwai1, Masayuki Kobayashi1, Norimitsu Kadowaki1, Reuben S Harris3, Akifumi Takaori-Kondo1.   

Abstract

Vif is essential for HIV-1 replication in T cells and macrophages. Vif recruits a host ubiquitin ligase complex to promote proteasomal degradation of the APOBEC3 restriction factors by poly-ubiquitination. The cellular transcription cofactor CBFβ is required for Vif function by stabilizing the Vif protein and promoting recruitment of a cellular Cullin5-RING ubiquitin ligase complex. Interaction between Vif and CBFβ is a promising therapeutic target, but little is known about the interfacial residues. We now demonstrate that Vif conserved residues E88/W89 are crucial for CBFβ binding. Substitution of E88/W89 to alanines impaired binding to CBFβ, degradation of APOBEC3, and virus infectivity in the presence of APOBEC3 in single-cycle infection. In spreading infection, NL4-3 with Vif E88A/W89A mutation replicated comparably to wild-type virus in permissive CEM-SS cells, but not in multiple APOBEC3 expressing non-permissive CEM cells. These results support a model in which HIV-1 Vif residues E88/W89 may participate in binding CBFβ.
© 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CBFβ; HIV-1; Host factors; Interaction; Vif

Mesh:

Substances:

Year:  2013        PMID: 24418540      PMCID: PMC3936105          DOI: 10.1016/j.virol.2013.11.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  DNA deamination mediates innate immunity to retroviral infection.

Authors:  Reuben S Harris; Kate N Bishop; Ann M Sheehy; Heather M Craig; Svend K Petersen-Mahrt; Ian N Watt; Michael S Neuberger; Michael H Malim
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

3.  Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.

Authors:  Ann M Sheehy; Nathan C Gaddis; Jonathan D Choi; Michael H Malim
Journal:  Nature       Date:  2002-07-14       Impact factor: 49.962

4.  The enzymatic activity of CEM15/Apobec-3G is essential for the regulation of the infectivity of HIV-1 virion but not a sole determinant of its antiviral activity.

Authors:  Keisuke Shindo; Akifumi Takaori-Kondo; Masayuki Kobayashi; Aierken Abudu; Keiko Fukunaga; Takashi Uchiyama
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

5.  CBFβ stabilizes HIV Vif to counteract APOBEC3 at the expense of RUNX1 target gene expression.

Authors:  Dong Young Kim; Eunju Kwon; Paul D Hartley; David C Crosby; Sumanjit Mann; Nevan J Krogan; John D Gross
Journal:  Mol Cell       Date:  2013-01-17       Impact factor: 17.970

6.  The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin.

Authors:  Sylvie Dussart; Marianne Courcoul; Gilles Bessou; Marc Douaisi; Yohann Duverger; Robert Vigne; Etienne Decroly
Journal:  Biochem Biophys Res Commun       Date:  2004-02-27       Impact factor: 3.575

7.  The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA.

Authors:  Hui Zhang; Bin Yang; Roger J Pomerantz; Chune Zhang; Shyamala C Arunachalam; Ling Gao
Journal:  Nature       Date:  2003-05-28       Impact factor: 49.962

8.  HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.

Authors:  Mariana Marin; Kristine M Rose; Susan L Kozak; David Kabat
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

9.  HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability.

Authors:  Kim Stopak; Carlos de Noronha; Wes Yonemoto; Warner C Greene
Journal:  Mol Cell       Date:  2003-09       Impact factor: 17.970

10.  The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif.

Authors:  Ann M Sheehy; Nathan C Gaddis; Michael H Malim
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

View more
  15 in total

1.  Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.

Authors:  Youwei Ai; Dantong Zhu; Cuihui Wang; Chao Su; Jian Ma; Jianzhang Ma; Xiaojun Wang
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

2.  Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.

Authors:  Wenyan Zhang; Hong Wang; Zhaolong Li; Xin Liu; Guanchen Liu; Reuben S Harris; Xiao-Fang Yu
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

3.  A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.

Authors:  Sizhu Duan; Shiqi Wang; Yanan Song; Nan Gao; Lina Meng; Yanxin Gai; Ying Zhang; Song Wang; Chu Wang; Bin Yu; Jiaxin Wu; Xianghui Yu
Journal:  J Biol Chem       Date:  2020-08-19       Impact factor: 5.157

4.  Dominant Negative Mutants of Human Immunodeficiency Virus Type 1 Viral Infectivity Factor (Vif) Disrupt Core-Binding Factor Beta-Vif Interaction.

Authors:  Sizhu Duan; Xin Yu; Chu Wang; Lina Meng; Yanxin Gai; Yan Zhou; Tiejun Gu; Bin Yu; Jiaxin Wu; Xianghui Yu
Journal:  J Virol       Date:  2022-08-11       Impact factor: 6.549

5.  Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Noriyoshi Yoshinaga; Kotaro Shirakawa; Masayuki Kobayashi; Akifumi Takaori-Kondo
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

6.  Inhibition of Vif-Mediated Degradation of APOBEC3G through Competitive Binding of Core-Binding Factor Beta.

Authors:  Eri Miyagi; Sarah Welbourn; Sayaka Sukegawa; Helena Fabryova; Sandra Kao; Klaus Strebel
Journal:  J Virol       Date:  2020-03-17       Impact factor: 5.103

7.  ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction.

Authors:  Kei Miyakawa; Satoko Matsunaga; Kazuhiko Kanou; Atsushi Matsuzawa; Ryo Morishita; Ayumi Kudoh; Keisuke Shindo; Masaru Yokoyama; Hironori Sato; Hirokazu Kimura; Tomohiko Tamura; Naoki Yamamoto; Hidenori Ichijo; Akifumi Takaori-Kondo; Akihide Ryo
Journal:  Nat Commun       Date:  2015-04-22       Impact factor: 14.919

Review 8.  Suppression of APOBEC3-mediated restriction of HIV-1 by Vif.

Authors:  Yuqing Feng; Tayyba T Baig; Robin P Love; Linda Chelico
Journal:  Front Microbiol       Date:  2014-08-26       Impact factor: 5.640

9.  Requirement of HIV-1 Vif C-terminus for Vif-CBF-β interaction and assembly of CUL5-containing E3 ligase.

Authors:  Hong Wang; Guoyue Lv; Xiaohong Zhou; Zhaolong Li; Xin Liu; Xiao-Fang Yu; Wenyan Zhang
Journal:  BMC Microbiol       Date:  2014-11-26       Impact factor: 3.605

10.  Identification of HIV-1 Vif regions required for CBF-β interaction and APOBEC3 suppression.

Authors:  Hong Wang; Bin Liu; Xin Liu; Zhaolong Li; Xiao-Fang Yu; Wenyan Zhang
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.